ViOptix, Inc. gives clinicians a revolutionary new capability — to obtain non-invasive, objective, real-time measurement of oxygen saturation (StO2) in the soft tissues affected by breast reconstruction and other surgical procedures – to help improve patient surgical outcomes by detecting problems before symptoms are visible.

ViOptix novel technology platform is built into three proprietary products:

Together, these products help to improve surgical outcomes, reduce patient time in the ICU, provide clinicians with faster feedback in the event of a problem and save money for the payer.

It’s objective. It’s reliable. It’s just the kind of device a microsurgeon would want to have.

Alex Keller, MD

how can we help you?

Use this form to send your questions or feedback. We will get back to as soon as possible.

I am Interested in

Clinical evaluationCustomer supportJob opportunitiesInvestor information

* Required fields